775 related articles for article (PubMed ID: 11563964)
1. GSK3 takes centre stage more than 20 years after its discovery.
Frame S; Cohen P
Biochem J; 2001 Oct; 359(Pt 1):1-16. PubMed ID: 11563964
[TBL] [Abstract][Full Text] [Related]
2. Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes.
Wagman AS; Johnson KW; Bussiere DE
Curr Pharm Des; 2004; 10(10):1105-37. PubMed ID: 15078145
[TBL] [Abstract][Full Text] [Related]
3. The kinase DYRK phosphorylates protein-synthesis initiation factor eIF2Bepsilon at Ser539 and the microtubule-associated protein tau at Thr212: potential role for DYRK as a glycogen synthase kinase 3-priming kinase.
Woods YL; Cohen P; Becker W; Jakes R; Goedert M; Wang X; Proud CG
Biochem J; 2001 May; 355(Pt 3):609-15. PubMed ID: 11311121
[TBL] [Abstract][Full Text] [Related]
4. GSK3 as a Sensor Determining Cell Fate in the Brain.
Cole AR
Front Mol Neurosci; 2012; 5():4. PubMed ID: 22363258
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels.
Yang K; Guo Y; Stacey WC; Harwalkar J; Fretthold J; Hitomi M; Stacey DW
BMC Cell Biol; 2006 Aug; 7():33. PubMed ID: 16942622
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.
Beurel E; Grieco SF; Jope RS
Pharmacol Ther; 2015 Apr; 148():114-31. PubMed ID: 25435019
[TBL] [Abstract][Full Text] [Related]
7. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
Dokken BB; Sloniger JA; Henriksen EJ
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
[TBL] [Abstract][Full Text] [Related]
8. GSK3-activated STAT5 regulates expression of SFRPs to modulate adipogenesis.
Wang L; Wang Y; Meng Y; Zhang C; Di L
FASEB J; 2018 Sep; 32(9):4714-4726. PubMed ID: 29579399
[TBL] [Abstract][Full Text] [Related]
9. A dual-kinase mechanism for Wnt co-receptor phosphorylation and activation.
Zeng X; Tamai K; Doble B; Li S; Huang H; Habas R; Okamura H; Woodgett J; He X
Nature; 2005 Dec; 438(7069):873-7. PubMed ID: 16341017
[TBL] [Abstract][Full Text] [Related]
10. Signalling specificity of Ser/Thr protein kinases through docking-site-mediated interactions.
Biondi RM; Nebreda AR
Biochem J; 2003 May; 372(Pt 1):1-13. PubMed ID: 12600273
[TBL] [Abstract][Full Text] [Related]
11. Characterization and development of novel small-molecules inhibiting GSK3 and activating Wnt signaling.
Zhong H; Zou H; Semenov MV; Moshinsky D; He X; Huang H; Li S; Quan J; Yang Z; Lin S
Mol Biosyst; 2009 Nov; 5(11):1356-60. PubMed ID: 19823752
[TBL] [Abstract][Full Text] [Related]
12. The glamour and gloom of glycogen synthase kinase-3.
Jope RS; Johnson GV
Trends Biochem Sci; 2004 Feb; 29(2):95-102. PubMed ID: 15102436
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase 3 alpha and 3 beta have distinct functions during cardiogenesis of zebrafish embryo.
Lee HC; Tsai JN; Liao PY; Tsai WY; Lin KY; Chuang CC; Sun CK; Chang WC; Tsai HJ
BMC Dev Biol; 2007 Aug; 7():93. PubMed ID: 17683539
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions.
Jope RS; Roh MS
Curr Drug Targets; 2006 Nov; 7(11):1421-34. PubMed ID: 17100582
[TBL] [Abstract][Full Text] [Related]
15. Macrophage Function and the Role of GSK3.
Patel S; Werstuck GH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672232
[TBL] [Abstract][Full Text] [Related]
16. The GSK3 kinase inhibitor lithium produces unexpected hyperphosphorylation of β-catenin, a GSK3 substrate, in human glioblastoma cells.
Abdul AURM; De Silva B; Gary RK
Biol Open; 2018 Jan; 7(1):. PubMed ID: 29212798
[TBL] [Abstract][Full Text] [Related]
17. Glycogen synthase kinase 3 regulates IL-1β mediated iNOS expression in hepatocytes by down-regulating c-Jun.
Lakshmanan J; Zhang B; Nweze IC; Du Y; Harbrecht BG
J Cell Biochem; 2015 Jan; 116(1):133-41. PubMed ID: 25160751
[TBL] [Abstract][Full Text] [Related]
18. Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease.
Russ C; Lovestone S; Powell JF
Mol Psychiatry; 2001 May; 6(3):320-4. PubMed ID: 11326302
[TBL] [Abstract][Full Text] [Related]
19. Receptor-dependent and tyrosine phosphatase-mediated inhibition of GSK3 regulates cell fate choice.
Kim L; Harwood A; Kimmel AR
Dev Cell; 2002 Oct; 3(4):523-32. PubMed ID: 12408804
[TBL] [Abstract][Full Text] [Related]
20. The Nav1.2 channel is regulated by GSK3.
James TF; Nenov MN; Wildburger NC; Lichti CF; Luisi J; Vergara F; Panova-Electronova NI; Nilsson CL; Rudra JS; Green TA; Labate D; Laezza F
Biochim Biophys Acta; 2015 Apr; 1850(4):832-44. PubMed ID: 25615535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
